0. Advocacy Graphic


  • June 13, 2017

    ASAM Sends Letters of Support for Bills to Repeal the IMD Exclusion

    ASAM sent letters of support for the Removing Barriers to Medicaid and CHIP Addiction Treatment Act and the Medicaid Coverage for Addiction Recovery Treatment Act. These bills would work to repeal Medicaid Institutions for the Mental Diseases (IMD) exclusion for mental health and substance use disorder residential treatment facilities. 
  • May 24, 2017

    ASAM and MISAM Submit Letter of Opposition to Bills That Would Limit Access to Addiction Treatment

    ASAM and MISAM submitted a letter of opposition to HB4404 and HB4405. These bills would create barriers to accessing treatment for addiction.
  • May 17, 2017

    ASAM Lead Coalition Letter Voicing Concern About Comments by HHS Secretary Tom Price

    ASAM led a coalition letter to HHS Secretary Tom Price expressing concern about comments he made in West Virginia suggesting that some forms of medication for opioid use disorder are superior to others, and that some are just replacing one opioid with another. The letter emphasizes how all three medications r approved by the FDA to treat opioid use disorder and are safe, effective, and help patients enter and sustain recovery and regain control of their lives.
  • May 16, 2017

    ASAM and WISAM Comment on Proposed Amendments to Wisconsin BadgerCare Reform Demonstration Waiver

    ASAM and the Wisconsin Society of Addiction Medicine submitted a letter to the Wisconsin Department of Health Services (DHS), Division of Medicaid Services on its proposed amendments to provisions of its Section 1115 Demonstration Waiver (BadgerCare Reform Demonstration Waiver).
  • May 8, 2017

    ASAM Joins Group Letter Supporting Continued Funding for ONDCP

    ASAM signed onto a letter sent to the Senior Advisor to the President regarding the Office of Management and Budget's (OMB) proposed budget which would slash funding for the Office of National Drug Control Policy (ONDCP) and drug control program funding.
  • May 5, 2017

    ASAM Submits Comments on the Administration's 2017 Drug Control Strategy

    ASAM led a coalition letter to the Acting Director of the Office of National Drug Control Policy urging the inclusion of the following essential provisions to address the opioid misuse and overdose epidemic in the Administration’s 2017 Drug Control Strategy.
  • May 3, 2017

    ASAM Leads Letter Expressing Concerns With the Finalized AHCA

    ASAM led a letter sent to House leadership expressing concerns with the finalized version of the American Health Care Act (AHCA). The letter was signed by 435 organizations representing consumers, families, providers, health care and social service professionals, advocates and allied organizations who are committed to meaningful and comprehensive policies to reduce the toll of substance use disorders and mental illness through prevention, treatment and recovery support services.
  • May 2, 2017

    ASAM Signs Onto Letter Urging Congress to Fund Cost-Sharing Reduction Payments

    ASAM joined 20 other organizations in sending a letter to Congressional leadership urging action on finding a bipartisan solution to ensure continued full funding of cost-sharing reduction payments (CSRs) to qualified health plans for eligible enrollees who have coverage through the exchanges.